Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6541 AL 6555

The singer or the singing: who sings individually to persons with dementia and what are the effects?

Chatterton W, Baker F, Morgan K.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):641-9. doi: 10.1177/1533317510385807.

Comparing responses to horticultural-based and traditional activities in dementia care programs

Jarrott SE, Gigliotti CM.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):657-65. doi: 10.1177/1533317510385810.

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin

Hamuro A, Saito S.

Psychogeriatrics. 2010 Dec;10(4):198-200. doi: 10.1111/j.1479-8301.2010.00338.x.

Overview of non-pharmacological intervention for dementia and principles of brain-activating rehabilitation

Yamaguchi H, Maki Y, Yamagami T.

Psychogeriatrics. 2010 Dec;10(4):206-13. doi: 10.1111/j.1479-8301.2010.00323.x. Epub 2010 Aug 28.

The Danish Alzheimer intervention study: rationale, study design and baseline characteristics of the cohort

Waldemar G, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A.

Neuroepidemiology. 2011;36(1):52-61. doi: 10.1159/000322942. Epub 2010 Dec 22.

Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy

Farlow MR, Grossberg GT, Meng X, Olin J, Somogyi M.

Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43. doi: 10.1002/gps.2669. Epub 2010 Dec 23.

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease

Niziński P, Szalast K, Makuch-Kocka A, Paruch-Nosek K, Ciechanowska M, Plech T.

Molecules. 2026 Jan 16;31(2):320. doi: 10.3390/molecules31020320.

Impact of Alzheimer's Disease Co-Pathology on Shunt Outcomes in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review and Meta-Analysis

Patwardhan A, Sharafkhah M, Borrie M, Bhangu J.

Mov Disord. 2026 May 4. doi: 10.1002/mds.70333. Online ahead of print.

The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential

Shu D, Fu C, Liu Z, Li C.

FEBS J. 2026 May 6. doi: 10.1111/febs.70574. Online ahead of print.

Phytoconstituents as Potential Therapeutics against Enzymatic Targets for Neurodegenerative Diseases

Singh H, Pandey VP.

Curr Protein Pept Sci. 2026;27(1):46-65. doi: 10.2174/0113892037350938250514110643.

Resveratrol and the neuroinflammation axis in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia

Wang H, Li F, Wang H, Tian Z, Fan H, Shi Z.

Front Immunol. 2026 Apr 21;17:1758356. doi: 10.3389/fimmu.2026.1758356. eCollection 2026.

Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques

Kakkar A, Singh H, Anand A, Chopra H, Mishra AK.

Curr Pharm Des. 2026;32(7):493-504. doi: 10.2174/0113816128373290250620054118.

The Ubiquitin-proteasome system in neuroinflammation and neurodegeneration: Molecular insights and therapeutic avenues

Guo Y, Wang N, Tao Z, Huang X, Yu W, Zeng J, Liu X, Chen S, Hua F, Wang X.

Int Immunopharmacol. 2026 Jun 15;179:116599. doi: 10.1016/j.intimp.2026.116599. Epub 2026 Apr 11.

[Acteoside: neurobiological activity spectrum, potential in the treatment of age-associated neurodegenerative diseases]

Berezutsky MA, Andronova TA, Belonogova YV, Durnova NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):41-47. doi: 10.17116/jnevro202612604141.

Protein S-sulfhydration: Mechanisms and therapeutic implications in Alzheimer's disease and Parkinson's disease

Guo J, Shi C, Yu C, Wang Y, He M.

Free Radic Biol Med. 2026 Mar 16;246:431-441. doi: 10.1016/j.freeradbiomed.2026.01.033. Epub 2026 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias